JP2015078201A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015078201A5 JP2015078201A5 JP2014233012A JP2014233012A JP2015078201A5 JP 2015078201 A5 JP2015078201 A5 JP 2015078201A5 JP 2014233012 A JP2014233012 A JP 2014233012A JP 2014233012 A JP2014233012 A JP 2014233012A JP 2015078201 A5 JP2015078201 A5 JP 2015078201A5
- Authority
- JP
- Japan
- Prior art keywords
- solid pharmaceutical
- group
- acid
- pharmaceutical composition
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000005843 halogen group Chemical group 0.000 claims 8
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 239000007787 solid Substances 0.000 claims 8
- 230000002378 acidificating effect Effects 0.000 claims 7
- 239000000126 substance Substances 0.000 claims 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 6
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000003277 amino group Chemical group 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 230000003796 beauty Effects 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 2
- 235000010443 alginic acid Nutrition 0.000 claims 2
- 239000000783 alginic acid Substances 0.000 claims 2
- 229960001126 alginic acid Drugs 0.000 claims 2
- 229920000615 alginic acid Polymers 0.000 claims 2
- 150000004781 alginic acids Chemical class 0.000 claims 2
- 235000003704 aspartic acid Nutrition 0.000 claims 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 238000007908 dry granulation Methods 0.000 claims 2
- 229910052731 fluorine Inorganic materials 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 239000001530 fumaric acid Substances 0.000 claims 2
- 235000011087 fumaric acid Nutrition 0.000 claims 2
- 239000004220 glutamic acid Substances 0.000 claims 2
- 235000013922 glutamic acid Nutrition 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 claims 2
- 235000018342 monosodium citrate Nutrition 0.000 claims 2
- 239000002524 monosodium citrate Substances 0.000 claims 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 2
- RPAJSBKBKSSMLJ-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCC(O)=O RPAJSBKBKSSMLJ-DFWYDOINSA-N 0.000 claims 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 235000015165 citric acid Nutrition 0.000 claims 1
- 229960003707 glutamic acid hydrochloride Drugs 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 235000011090 malic acid Nutrition 0.000 claims 1
- 239000001630 malic acid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 235000002906 tartaric acid Nutrition 0.000 claims 1
- 239000011975 tartaric acid Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014233012A JP6391436B2 (ja) | 2013-04-25 | 2014-11-17 | 固形医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013092171 | 2013-04-25 | ||
| JP2013092171 | 2013-04-25 | ||
| JP2014233012A JP6391436B2 (ja) | 2013-04-25 | 2014-11-17 | 固形医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014541237A Division JP5651812B1 (ja) | 2013-04-25 | 2014-04-24 | 固形医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015078201A JP2015078201A (ja) | 2015-04-23 |
| JP2015078201A5 true JP2015078201A5 (enExample) | 2017-06-15 |
| JP6391436B2 JP6391436B2 (ja) | 2018-09-19 |
Family
ID=51791434
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014541237A Active JP5651812B1 (ja) | 2013-04-25 | 2014-04-24 | 固形医薬組成物 |
| JP2014233012A Active JP6391436B2 (ja) | 2013-04-25 | 2014-11-17 | 固形医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014541237A Active JP5651812B1 (ja) | 2013-04-25 | 2014-04-24 | 固形医薬組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9603804B2 (enExample) |
| EP (1) | EP2990038B1 (enExample) |
| JP (2) | JP5651812B1 (enExample) |
| CN (1) | CN105338982B (enExample) |
| CA (1) | CA2910112C (enExample) |
| ES (1) | ES2768651T3 (enExample) |
| WO (1) | WO2014174846A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014174847A1 (ja) | 2013-04-25 | 2014-10-30 | 杏林製薬株式会社 | 固形医薬組成物 |
| JP6018334B2 (ja) * | 2014-10-23 | 2016-11-02 | 杏林製薬株式会社 | 固形医薬組成物 |
| EP3210608A4 (en) * | 2014-10-23 | 2018-06-20 | Kyorin Pharmaceutical Co., Ltd. | Solid pharmaceutical composition |
| US10406149B2 (en) | 2015-06-02 | 2019-09-10 | Kyorin Pharmaceutical Co., Ltd. | Aqueous liquid formulation |
| US10617684B2 (en) | 2015-06-02 | 2020-04-14 | Kyorin Pharmaceutical Co., Ltd. | Aqueous drug |
| JP6031216B1 (ja) * | 2015-06-02 | 2016-11-24 | 杏林製薬株式会社 | 水性液剤 |
| JP6031217B1 (ja) * | 2015-06-02 | 2016-11-24 | 杏林製薬株式会社 | 水性液剤 |
| WO2016195020A1 (ja) * | 2015-06-02 | 2016-12-08 | 杏林製薬株式会社 | 水性液剤 |
| EP3773579A4 (en) | 2018-03-26 | 2022-03-09 | Clear Creek Bio, Inc. | COMPOSITIONS AND METHODS FOR INHIBITING DIHYDROOROTATE DEHYDROGENASE |
| US20210308117A1 (en) | 2020-03-20 | 2021-10-07 | Clear Creek Bio, Inc. | Methods of treating viral infections using inhibitors of nucleotide synthesis pathways |
| JP2023518419A (ja) * | 2020-03-20 | 2023-05-01 | クリア クリーク バイオ， インコーポレイテッド | ブレキナルナトリウムの安定した多形性組成物ならびにその使用および製造方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8524001D0 (en) | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
| KR940000232B1 (ko) | 1986-01-17 | 1994-01-12 | 쥬우가이세이야꾸 가부시끼가이샤 | 니코란딜 제제의 안정화 방법 |
| ZA87279B (en) | 1986-01-17 | 1987-09-30 | Chugai Pharmaceutical Co Ltd | Method for production of stable nicorandil preparation |
| JP2512302B2 (ja) | 1986-03-19 | 1996-07-03 | 中外製薬株式会社 | ニコランジル安定化製剤の製造方法 |
| KR910700043A (ko) | 1988-12-28 | 1991-03-13 | 우에하라 아끼라 | 타정시에 있어서 응력분산 방법 |
| TW284688B (enExample) | 1991-11-20 | 1996-09-01 | Takeda Pharm Industry Co Ltd | |
| JP2682353B2 (ja) | 1991-11-20 | 1997-11-26 | 武田薬品工業株式会社 | 経口用医薬組成物およびその製造法 |
| JP2006111639A (ja) | 1993-10-21 | 2006-04-27 | Takeda Chem Ind Ltd | 医薬用錠剤 |
| JPH08175996A (ja) | 1994-12-22 | 1996-07-09 | Taiyo Yakuhin Kogyo Kk | ニコランジル安定化固形製剤の製法 |
| JP3119801B2 (ja) | 1995-09-28 | 2000-12-25 | 武田薬品工業株式会社 | ビタミン含有組成物の安定化方法 |
| JPH10245335A (ja) | 1997-02-28 | 1998-09-14 | Dainippon Pharmaceut Co Ltd | 圧力に不安定な薬物の打錠方法及びそれに用いられる湿潤顆粒 |
| EP1066040B1 (en) | 1998-03-03 | 2003-02-19 | Daewoong Pharmaceutical Co., Ltd. | Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption |
| AT413647B (de) | 1998-11-26 | 2006-04-15 | Sandoz Ag | Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten |
| DE10048510A1 (de) | 2000-09-29 | 2002-05-16 | Fresenius Kabi De Gmbh | Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt |
| BR0207640A (pt) | 2001-02-27 | 2004-07-27 | Ranbaxy Lab Ltd | Composição farmacêutica oral de cefpodoxima proxetil |
| US7219132B2 (en) | 2001-03-30 | 2007-05-15 | Space Systems/Loral | Dynamic resource allocation architecture for differentiated services over broadband communication networks |
| ATE443064T1 (de) | 2002-03-18 | 2009-10-15 | Kyorin Seiyaku Kk | 10-(3-cyclo propyl amino methyl-1-pyrrolidinyl) pyridobenzoxazin carbonsäure derivat mit wirkung gegen resistente bakterien |
| EP1459739B1 (en) | 2003-03-19 | 2008-01-02 | The Jordanian Pharmaceutical Manufacturing Co. Ltd. | Non-hygroscopic pharmaceutical compositions containing non-hydrated quinoline carboxylic acids |
| SI1666477T1 (sl) | 2003-09-10 | 2013-10-30 | Kyorin Pharmaceutical Co., Ltd. | Derivati 7-(4-substituiran 3-ciklopropilaminometil-1-pirolidinil) kinolonkarboksilne kisline |
| EP1764102A4 (en) | 2004-07-02 | 2010-08-25 | Daiichi Seiyaku Co | MEDICINAL COMPOSITION CONTAINING QUINOLONE |
| JP4834553B2 (ja) | 2004-09-17 | 2011-12-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 医薬組成物 |
| US20080031942A1 (en) | 2004-12-03 | 2008-02-07 | Takeda Pharmaceutical Company Limited | Solid Preparation |
| AR052559A1 (es) | 2005-01-21 | 2007-03-21 | Astex Therapeutics Ltd | Derivados de pirazol para inhibir cdk's y gsk's |
| ATE518526T1 (de) | 2005-01-26 | 2011-08-15 | Lek Pharmaceuticals | Neue pharmazeutische zusammensetzung mit candesartan-cilexetil als lipophile kristalline substanz |
| JP2006298811A (ja) | 2005-04-20 | 2006-11-02 | Taiyo Yakuhin Kogyo Kk | ゲル化抑制製剤の設計 |
| SA112330992B1 (ar) * | 2011-11-10 | 2015-09-13 | كيورين فارماسوتيكال كو.، ليمتد | صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي |
| WO2013145749A1 (ja) | 2012-03-29 | 2013-10-03 | 杏林製薬株式会社 | カプセル製剤 |
| JP6062422B2 (ja) * | 2012-03-29 | 2017-01-18 | 杏林製薬株式会社 | カプセル製剤 |
| WO2014174847A1 (ja) | 2013-04-25 | 2014-10-30 | 杏林製薬株式会社 | 固形医薬組成物 |
-
2014
- 2014-04-24 US US14/786,394 patent/US9603804B2/en not_active Expired - Fee Related
- 2014-04-24 EP EP14787908.4A patent/EP2990038B1/en active Active
- 2014-04-24 WO PCT/JP2014/002308 patent/WO2014174846A1/ja not_active Ceased
- 2014-04-24 CA CA2910112A patent/CA2910112C/en not_active Expired - Fee Related
- 2014-04-24 ES ES14787908T patent/ES2768651T3/es active Active
- 2014-04-24 CN CN201480036231.6A patent/CN105338982B/zh active Active
- 2014-04-24 JP JP2014541237A patent/JP5651812B1/ja active Active
- 2014-11-17 JP JP2014233012A patent/JP6391436B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015078201A5 (enExample) | ||
| SA517390583B1 (ar) | مشتقات حمض أميني جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها | |
| WO2017205536A3 (en) | Heterocyclic inhibitors of cbp/ep300 and their use in the treatment of cancer | |
| ZA201507958B (en) | New somatostatin receptor subtype 4 (sstr4)agonists | |
| JP2015110646A5 (enExample) | ||
| JP2018531941A5 (enExample) | ||
| CA2983453A1 (en) | Naphthyridine compounds as jak kinase inhibitors | |
| MD20140072A2 (ro) | Noi compuşi ai pirolului, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin | |
| JP2015063536A5 (enExample) | ||
| EA201691590A1 (ru) | Бензимидазол-2-амины в качестве ингибиторов midhi | |
| TN2016000581A1 (en) | Heteroaryl compounds useful as inhibitors of sumo activating enzyme | |
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| MY160785A (en) | Manufacturing process for pyrimidine derivatives | |
| ZA201805185B (en) | Tlr7 agonist maleate salt, crystalline forms c, d and e thereof, preparation methods and uses of maleate salt and crystalline forms | |
| MX2021006790A (es) | Formulacion de tableta para compuestos activos de peptido relacionado con el gen de calcitonina. | |
| EA201691136A1 (ru) | Производное на основе 1,2-нафтохинона и способ его получения | |
| HRP20241103T1 (hr) | 2,4-di-(skupina koja sadrži dušik)-supstituirani pirimidinski spoj i postupak pripreme i njegova upotreba | |
| MX2016001096A (es) | Sales de dasatinib en forma amorfa. | |
| EA201691538A1 (ru) | Способ получения солей вортиоксетина | |
| CN110891950A (zh) | 一种三嗪化合物及其药学上可接受的盐 | |
| MX379859B (es) | Compuestos de indolinona y su uso en el tratamiento de enfermedades fibróticas. | |
| MX2016001095A (es) | Sales de dasatinib en forma cristalina. | |
| PH12019500822B1 (en) | Crystalline forms of eravacycline | |
| MA39715A (fr) | Formes polymorphes de l'acide 4,5-dihydro-1h-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylique et de son sel de disodium, procédé de préparation desdites formes polymorphes et leur utilisation | |
| EA201892020A1 (ru) | Индольные производные и их применение в качестве ингибиторов протеинкиназы |